GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IntelliPharmaCeutics International Inc (OTCPK:IPCIF) » Definitions » Days Payable
中文

IntelliPharmaCeutics International (IntelliPharmaCeutics International) Days Payable : 19,091.53 (As of Aug. 2023)


View and export this data going back to 1996. Start your Free Trial

What is IntelliPharmaCeutics International Days Payable?

IntelliPharmaCeutics International's average Accounts Payable for the three months ended in Aug. 2023 was $3.77 Mil. IntelliPharmaCeutics International's Cost of Goods Sold for the three months ended in Aug. 2023 was $0.02 Mil. Hence, IntelliPharmaCeutics International's Days Payable for the three months ended in Aug. 2023 was 19,091.53.

The historical rank and industry rank for IntelliPharmaCeutics International's Days Payable or its related term are showing as below:

IPCIF' s Days Payable Range Over the Past 10 Years
Min: 32.26   Med: 754.16   Max: 78681.83
Current: 78681.83

During the past 13 years, IntelliPharmaCeutics International's highest Days Payable was 78681.83. The lowest was 32.26. And the median was 754.16.

IPCIF's Days Payable is ranked better than
98.18% of 715 companies
in the Biotechnology industry
Industry Median: 148.78 vs IPCIF: 78681.83

IntelliPharmaCeutics International's Days Payable increased from Aug. 2022 (0.00) to Aug. 2023 (19,091.53). It may suggest that IntelliPharmaCeutics International delayed paying its suppliers.


IntelliPharmaCeutics International Days Payable Historical Data

The historical data trend for IntelliPharmaCeutics International's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IntelliPharmaCeutics International Days Payable Chart

IntelliPharmaCeutics International Annual Data
Trend Nov13 Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,866.38 34,352.94 - - -

IntelliPharmaCeutics International Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 19,091.53

Competitive Comparison of IntelliPharmaCeutics International's Days Payable

For the Biotechnology subindustry, IntelliPharmaCeutics International's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IntelliPharmaCeutics International's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IntelliPharmaCeutics International's Days Payable distribution charts can be found below:

* The bar in red indicates where IntelliPharmaCeutics International's Days Payable falls into.



IntelliPharmaCeutics International Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

IntelliPharmaCeutics International's Days Payable for the fiscal year that ended in Nov. 2022 is calculated as

Days Payable (A: Nov. 2022 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Nov. 2021 ) + Accounts Payable (A: Nov. 2022 )) / count ) / Cost of Goods Sold (A: Nov. 2022 )*Days in Period
=( (3.78 + 3.765) / 2 ) / 0*365
=3.7725 / 0*365
=N/A

IntelliPharmaCeutics International's Days Payable for the quarter that ended in Aug. 2023 is calculated as:

Days Payable (Q: Aug. 2023 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: May. 2023 ) + Accounts Payable (Q: Aug. 2023 )) / count ) / Cost of Goods Sold (Q: Aug. 2023 )*Days in Period
=( (3.673 + 3.859) / 2 ) / 0.018*365 / 4
=3.766 / 0.018*365 / 4
=19,091.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IntelliPharmaCeutics International Days Payable Related Terms

Thank you for viewing the detailed overview of IntelliPharmaCeutics International's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


IntelliPharmaCeutics International (IntelliPharmaCeutics International) Business Description

Traded in Other Exchanges
Address
30 Worcester Road, Toronto, ON, CAN, M9W 5X2
IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.

IntelliPharmaCeutics International (IntelliPharmaCeutics International) Headlines

From GuruFocus

Intellipharmaceutics Reports Director Election Results

By ACCESSWIRE ACCESSWIRE 12-24-2020

Intellipharmaceutics Comments on Recent Trading Activity

By ACCESSWIRE ACCESSWIRE 12-22-2021